Woman Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective is to determine if metastatic breast cancer patients with HER2-negative primary tumors but with at least one HER2-positive CTC benefit from trastuzumab-containing chemotherapy.
Inclusion criteria
- Metastastic breast cancer